Table 1.
Demographic and clinical data on recipients, graft characteristics, and surgical details.
| Gender (M:F) | 291:33 |
| Age (years) | 58 (52–62) |
| BMI | 25.3 (23.2–28.1) |
| Pre-LT diabetes (%) | 54 (16.9%) |
| HIV positivity (%) | 29 (9.0%) |
| HCV positivity (%) | 180 (55.6%) |
| HBV positivity (%) | 70 (21.6%) |
| Alcohol abuse (%) | 96 (29.6%) |
| MELD score | 12 (9–16) |
| Child–Pugh score (%) | |
| - A | 139 (42.9%) |
| - B | 122 (37.6%) |
| - C | 62 (19.5%) |
| Pre-LT PLR | 74.2 (50.3–108.5) |
| 1 year post-LT PLR | 118.2 (79.1–161.5) |
| Pre-LT NLR | 2.9 (1.9–4.8) |
| 1 year post-LT NLR | 2.4 (1.7–3.7) |
| Pre-LT PNI | 38.6 (34.5–44.1) |
| 1 year post-LT PNI | 45.6 (41.9–49.5) |
| Pre-LT CONUT | 5 (3–7) |
| 1 year post-LT CONUT | 2 (1–3) |
| Pre-LT AFP, (ng/L) | 9.8 (4.6–40.2) |
| Donor age (years) | 61.4 (50.1–72.9) |
| Donor BMI | 25.8 (23.7–27.8) |
| Total ischemia time (min) | 470 (401–550) |
| Packed blood cells transfusion, (UI) | 3 (0–7) |
| Frozen fresh plasma transfusion, (mL) | 1000 (0–2000) |
| Tumor number | 2 (1–3) |
| Tumor max diameter (cm) | 2.3 (1.5–3) |
| Bilobar tumor distribution (%) | 82 (25.3%) |
| Edmonson–Steiner grading (%) | |
| - Complete necrosis | 12 (3.7%) |
| - G1 | 54 (16.6%) |
| - G2 | 172 (53.1%) |
| - G3 | 80 (24.7%) |
| - G4 | 6 (1.9%) |
| Microvascular invasion (%) | 50 (15.4%) |
AFP: Alpha-Fetoprotein, BMI: body mass index, CONUT: controlling nutritional status, HBV: hepatitis B virus, HCV: hepatitis C virus, HIV: human immunodeficiency virus, HCC: hepatocellular carcinoma, LT: liver transplantation, MELD: Model for end-stage liver disease, NLR: Neutrophil-to-Lymphocyte Ratio, PLR: Platelet-to-Lymphocyte Ratio, PNI: Prognostic Nutritional Index.